Core Laboratories (CLB) Fundamentals 2026 — P/E 18.3x, Revenue Analysis | SniperIQ

1.89 on the NYSE. This SniperIQ fundamentals page covers Core Laboratories's valuation (P/E 18.3x, P/B 2.0x), profitability (net margin 5.5%), revenue ($527M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Full research coverage

• 8-Quarter Revenue & Margin Trend
• Debt Maturity & Coverage
• Peer Valuation Comparison
• Free Cash Flow & Owner Earnings
• AI Signal + Institutional Flow
• DCF Valuation Model

Frequently Asked Questions

What is Core Laboratories's market cap?

Core Laboratories (CLB) has a market capitalization of approximately $548M, trading at

1.89 on the NYSE. Market cap moves with the live share price.

What is Core Laboratories's P/E ratio?

Core Laboratories's trailing twelve-month P/E ratio is 18.3x, with a price-to-book (P/B) of 2.0x. Valuation multiples are best compared with Energy sector peers rather than read in isolation.

How profitable is Core Laboratories?

Core Laboratories runs a net profit margin of 5.5%, a gross margin of 17.8%, and an operating margin of 10.3%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does Core Laboratories generate?

Core Laboratories reported revenue of $527M for fiscal year 2025, with net income of

0M and earnings per share (EPS) of 0.68. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does Core Laboratories pay a dividend?

Core Laboratories offers a trailing dividend yield of about 0.3%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.

Is Core Laboratories financially healthy?

Core Laboratories carries a debt-to-equity ratio of 0.62x and a current ratio of 2.05x, with a market beta of 1.01. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is Core Laboratories a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Core Laboratories (CLB) the key facts are: market cap $548M, P/E 18.3x, revenue $527M, 52-week range 9.72-20.36. Weigh valuation, profitability, growth, and balance-sheet strength against Energy peers and form your own view.